BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pacher P, Kogan NM, Mechoulam R. (2019) Beyond THC and Endocannabinoids. Annual Review of Pharmacology and Toxicology
Petrie GN, Wills KL, Piscitelli F, et al. (2019) Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats. Psychopharmacology
Alcina AG, Stevenson LA, Haj C, et al. (2019) A synthetic analogue of cannabidiolic acid that acts like a positive allosteric modulator at 5-HT1A receptors British Journal of Pharmacology. 176: 3011-3012
Pertwee RG, Rock EM, Guenther K, et al. (2017) Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats. British Journal of Pharmacology
Silva NR, Gomes FV, Fonseca MD, et al. (2017) Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative. Progress in Neuro-Psychopharmacology & Biological Psychiatry
Rock EM, Boulet N, Limebeer CL, et al. (2016) Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats. European Journal of Pharmacology
Maslov LN, Khaliulin I, Zhang Y, et al. (2015) Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists. Journal of Cardiovascular Pharmacology and Therapeutics
Haj CG, Sumariwalla PF, Hanuš L, et al. (2015) HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid. The Journal of Pharmacology and Experimental Therapeutics. 355: 66-75
Kozela E, Haj C, Hanuš L, et al. (2015) HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells. Chemical Biology & Drug Design
Smoum R, Baraghithy S, Chourasia M, et al. (2015) CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. Proceedings of the National Academy of Sciences of the United States of America. 112: 8774-9
See more...